Hi Guest
X
Real-Time Quote
Enter Company or MFGlaxoSmithKline Pharmaceuticals Ltd. - Research Center
Results |
Annual |
Statement | |
More |
(Rs crore)
Annual results in brief
| Dec ' 08 | Dec ' 07 | Dec ' 06 | Dec ' 05 | Dec ' 04 | |
|---|---|---|---|---|---|
| Sales | 1,680.68 | 1,712.84 | 1,677.57 | 1,575.89 | 1,479.59 |
| Operating profit | 597.96 | 497.23 | 475.96 | 428.00 | 384.82 |
| Interest | -70.02 | - | - | - | - |
| Gross profit | 696.24 | 627.34 | 571.80 | 493.64 | 435.71 |
| EPS (Rs) | 68.07 | 63.48 | 64.40 | 59.28 | 38.15 |
Annual results in details
| Dec ' 08 | Dec ' 07 | Dec ' 06 | Dec ' 05 | Dec ' 04 | |
|---|---|---|---|---|---|
| Other income | 28.26 | 130.11 | 95.84 | 65.64 | 50.89 |
| Stock adjustment | -2.33 | 32.73 | -12.53 | 0.54 | -3.18 |
| Raw material | 351.87 | 595.73 | 637.05 | 625.92 | 594.04 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 172.75 | 151.26 | 153.67 | 155.48 | 144.08 |
| Excise | -4.88 | 142.54 | 139.15 | 105.51 | 103.70 |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 565.31 | 293.35 | 284.27 | 260.44 | 256.13 |
| Provisions made | - | - | - | - | - |
| Depreciation | 16.34 | 16.16 | 15.85 | 15.73 | 17.47 |
| Taxation | 231.54 | 211.46 | 194.23 | 171.63 | 152.19 |
| Net profit / loss | 576.57 | 537.66 | 545.51 | 502.08 | 333.09 |
| Extra ordinary item | 128.21 | 137.94 | 183.79 | 195.80 | 67.04 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 84.70 | 84.70 | 84.70 | 84.70 | 87.32 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | 417.86 | 417.86 | 417.86 | 417.86 | 444.05 |
| Agg.of non promotoHolding (%) | 49.30 | 49.30 | 49.30 | 49.30 | 51.00 |
| OPM (%) | 35.58 | 29.03 | 28.37 | 27.16 | 26.01 |
| GPM (%) | 40.74 | 34.04 | 32.24 | 30.07 | 28.47 |
| NPM (%) | 33.74 | 29.17 | 30.76 | 30.59 | 21.76 |